Boston Scientific Corporation (BSX) has a consensus analyst rating of Buy, based on 43 analysts covering the stock. Of those, 40 recommend buying, 3 recommend holding, and 0 recommend selling.
The analyst consensus price target for BSX is $108.35, representing a +69.8% upside from the current price of $63.82. Price targets range from a low of $94.00 to a high of $130.00.
